XML 27 R9.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock-Based Compensation
3 Months Ended
Mar. 29, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
STOCK-BASED COMPENSATION
Employee Share Purchase Plan
At our 2014 Annual Meeting of Shareholders, which was held on May 8, 2014, our shareholders approved an amendment to our Employee Share Purchase Plan to increase the number of shares of our common stock reserved for issuance under the plan from 3,950,000 to 4,200,000.
1995 Stock Incentive Plan
Also at our 2014 Annual Meeting of Shareholders, our shareholders approved an amendment to our 1995 Stock Incentive Plan (the “1995 Plan”) to increase the number of shares of our common stock reserved for issuance under the plan from 11,000,000 to 11,250,000.
The following table sets forth certain information regarding the 1995 Plan:
 
March 29,
2015
Shares available for grant
1,909,185

Shares of common stock reserved for issuance pursuant to outstanding exercisable securities
3,236,286


The following table sets forth certain information regarding all options outstanding and exercisable:
 
March 29, 2015
 
Options
Outstanding
 
Options
Exercisable
Number
779,158

 
299,095

Weighted average exercise price
$
62.38

 
$
45.79

Aggregate intrinsic value
$ 13.4 million

 
$ 9.4 million

Weighted average remaining contractual term
4.7 years

 
3.5 years


The following table sets forth certain information regarding all RSUs nonvested and expected to vest:
 
March 29, 2015
 
RSUs Nonvested
 
RSUs Expected
to Vest
Number
547,945

 
488,536

Weighted average grant date per share fair value
$
70.86

 
$
70.25

Aggregate intrinsic value
$ 41.3 million

 
$ 36.9 million

Weighted average remaining term to vest
1.3 years

 
1.3 years


As of March 29, 2015, unrecognized stock-based compensation related to outstanding, but unvested stock options and RSUs was $36.9 million, which will be recognized over the weighted average remaining vesting period of 1.7 years.
Stock-Based Compensation Expense
Our stock-based compensation expense was included in our consolidated statements of operations as follows (in thousands):
 
Thirteen Weeks Ended
 
March 29,
2015
 
March 30,
2014
Cost of sales
$
792

 
$
726

Research and development
630

 
617

Selling, general and administrative
4,527

 
3,796

Total stock-based compensation
$
5,949

 
$
5,139